Engineers Gate Manager’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Engineers Gate Manager’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,377	Closed	-$368K	–	2308
2024 Q1	$368K	Buy	+23,377	New	+$360K	0.01%	1359
2023 Q4	–	Sell	-26,857	Closed	-$342K	–	2335
2023 Q3	$342K	Buy	+26,857	New	+$371K	0.01%	1254
2023 Q2	–	Sell	-24,079	Closed	-$372K	–	2104
2023 Q1	$372K	Buy	24,079 +13,122	+120%	+$219K	0.02%	1134
2022 Q4	$180K	Sell	10,957 -11,723	-52%	-$191K	0.01%	1402
2022 Q3	$420K	Buy	+22,680	New	+$356K	0.03%	918

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Engineers Gate Manager's DCPH Position: Q2 2024 in Review

Engineers Gate Manager sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 23,377 shares — an estimated $368K sold.

Engineers Gate Manager first reported a position in DCPH in Q3 2022 and held it in 5 quarters. The position peaked at $420K in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Engineers Gate Manager reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Engineers Gate Manager sold 23,377 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $368K.
Engineers Gate Manager first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Engineers Gate Manager's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $420K in Q3 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Engineers Gate Manager's 13F filing for Q2 2024, filed 14 Aug 2024.